AGP Executive Report
Last update: 3 hours agoPain Research: A two-year UK study of 3,744 chronic-pain patients found medical cannabis use was associated with improvements in pain, sleep, anxiety and quality of life. Researchers caution that the observational study cannot prove cannabis caused the changes. Product Safety: A Colorado audit found nearly 75% of marijuana processed for sale from 2023 to 2025 avoided pesticide testing, while delayed warnings and gaps in inspections may have left consumers exposed to contaminated products. Medical Access: Kentucky now has a dispensary in each of its 11 regions, expanding access as the state’s program continues to grow. Hemp Rules: Federal restrictions on intoxicating hemp products are approaching, with a Dec. 12 deadline raising uncertainty for businesses and consumers. Health Questions: Recent reports challenge claims that cannabis improves sleep and flag a possible higher heart-attack risk around surgery; the findings add to ongoing questions about who may benefit and who could face harm.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
